BDP1 and breast carcinoma: In neuroblastoma, two BDP1 variants were identified to be associated with poor clinical outcomes36 and recently, BDP1 expression has been correlated with clinical outcomes in non‐Hodgkin lymphoma (NHL)35 and breast cancer.34